Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma Clinical Trials in Beijing, Beijing Municipality

Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab